H. Lundbeck A/s

This study tested whether adding eptinezumab (a migraine prevention drug) to a brief educational program helps adults who have both migraines and medication overuse headache. Over 600 participants were followed to see if the drug reduced the number of migraine days and headache d…

This study tested a drug called eptinezumab to see if it could prevent migraines in people with chronic migraine (15 or more headache days per month, at least 8 being migraine). About 981 adults took part. The main goal was to see if the drug reduced the number of migraine days e…

This study looked at the long-term safety of eptinezumab, a medicine used to prevent migraines. It involved 160 Japanese patients who had already completed a previous study. The goal was to see if the drug remained safe and tolerable over an extended period of up to 60 weeks.

This early-stage study tested a new drug called Lu AF28996 in 57 people with Parkinson's disease. The main goal was to see if the drug is safe and how the body processes it. Researchers measured side effects and drug levels in the blood. This is a first step to see if the drug mi…

This early-stage study looked at whether a new drug called Lu AG09222 is safe to take together with the migraine medication ubrogepant. 43 people with migraine received ubrogepant pills plus an injection of either Lu AG09222 or a placebo. The main goal was to check for any side e…